肠漏的机制及临床意义

张西; 石汉平

doi:10.16689/j.cnki.cn11-9349/r.2020.01.024

PDF(615 KB)

肿瘤代谢与营养电子杂志 ›› 2020, Vol. 7 ›› Issue (1) : 131-136. DOI: 10.16689/j.cnki.cn11-9349/r.2020.01.024

综述

肠漏的机制及临床意义

张西，石汉平

作者信息 +

Leaky gut：mechanisms and clinical implications

Zhang Xi, Shi Hanping

Author information +

文章历史 +

摘要

肠上皮细胞及细胞间连接的完整性在防止肠腔内的有害物质进入体内方面发挥着重要作用。肠漏是指肠道机械屏障功能受损，肠上皮细胞间的细胞旁路途径异常开放，导致肠道通透性升高。肠漏被宣传为可引发多种非肠道疾病及临床症状，严重威胁着人类健康，但这种说法缺乏临床研究数据支持，夸大了肠漏在疾病发生、发展中的作用。因此如何客观看待肠漏与疾病的关系，有助于临床医生诊断和治疗肠道通透性升高所致的疾病。本综述将从肠道机械屏障与肠道通透性的关系、肠道通透性的检测方法、肠道通透性与疾病的关系等方面论述肠漏的机制及临床意义。

Abstract

A contiguous layer of cells as well as the junctions that seal the paracellular space play a fundamental function to separate luminal harmful contents from the interstitium. Leaky gut resulted from impaired mechanical barrier and dysfunctional paracellular pathway, leading to increased intestinal permeability. Leaky gut has been proposed to be associated with a number of disease states, but there is a lack of valid clinical data supporting such proposal. Therefore, it is important to provide a balanced view of the association between leaky gut and diseases to facilitate the diagnosis and treatment of disease associated with increased intestinal permeability. This review summarizes the mechanism and clinical significance of leaky gut from aspects including the relationship between mechanical intestinal barrier and intestinal permeability, measurement of intestinal permeability, and intestinal permeability in disease states.

导出引用

张西，石汉平. 肠漏的机制及临床意义[J]. 肿瘤代谢与营养电子杂志. 2020, 7(1): 131-136 https://doi.org/10.16689/j.cnki.cn11-9349/r.2020.01.024

Zhang Xi, Shi Hanping. Leaky gut：mechanisms and clinical implications[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2020, 7(1): 131-136 https://doi.org/10.16689/j.cnki.cn11-9349/r.2020.01.024

参考文献

1.Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology. 1977；73：247-251.
2.Bjarnason I, Peters T, Veall N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet. 1983；321：323-325.
3.Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability：a new target for disease prevention and therapy. BMC Gastroenterol. 2014；14：189.
4.Meaney C, ODriscoll C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur J Pharm Sci. 1999；8：167-175.
5.Glade MJ, Meguid MM. A glance at dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber. Nutrition. 2016；32：609-614.
6.Hecht G. Innate mechanisms of epithelial host defense：spotlight on intestine. Am J Physiol. 1999；277(3)：C351-C358.
7.Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009；9：799-809.
8.Shen L, Weber CR, Raleigh DR, et al. Tight junction pore and leak pathways：a dynamic duo. Annu Rev Physiol. 2011；73：283-309.
9.Odenwald MA, Turner JR. Intestinal permeability defects：is it time to treat? Clin Gastroenterol Hepatol. 2013；11：1075-1083.
10.Bergmann KR, Liu SX, Tian R, et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol. 2013；182：1595-1606.
11.Terciolo C, Dapoigny M, Andre F. Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption. Clin Exp Gastroenterol. 2019；12：67-82.
12.Ukena SN, Singh A, Dringenberg U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One. 2007；2：e1308.
13.Zareie M, Riff J, Donato K, et al. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microb.2005；7：1782-1797.
14.Garcia-Gutierrez E, Mayer MJ, Cotter PD, et al. Gut microbiota as a source of novel antimicrobials. Gut Microbes. 2019；10(1)：1-21.
15.Sorg JA, Sonenshein AL. Bile salts and glycine as co-germinants for Clostridium difficile spores. J Bacteriol. 2008；190：2505-2512.
16.Summa KC, Voigt RM, Forsyth CB, et al. Disruption of the Circadian clock in mice increases intestinal permeability and promotes alcohol-induced hepatic pathology and inflammation. PLoS One. 2013；8：e67102.
17.Vanuytsel T, van Wanrooy S, Vanheel H, et al. Psychological stress and corticotropinreleasing hormone increase intestinal permeability in humans by a mast celldependent mechanism. Gut. 2014；63：1293-1299.
18.Rao AS, Camilleri M, Eckert DJ, et al. Urine sugars for in vivo gut permeability：validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol. 2011；301：G919-G928.
19.Camilleri M. Leaky gut：mechanisms, measurement and clinical implications in humans. Gut. 2019；68(8)：1516-1526.
20.Turck D, Ythier H, Maquet E, et al. Intestinal permeability to ［51Cr］EDTA in children with Crohns disease and celiac disease. J Pediatr Gastroenterol Nutr. 1987；6(4)：535-537.
21.Ameno H, Tani T, Hanasawa K,et al. New method for the detection of bacterial translocation using intestinal permeability with polyethylene glycol 4000. Eur Surg Res. 2000；32(1)：23-29.
22.Zhang Q,Li QR, Wang M, et al. Synergistic effects of interferon-γ and tumour necrosis factor-α on intestinal epithelium tight junction. PARENTERAL & ENTERAL NUTRITION. 2006；13：335-337.
23.Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014；147：1012-1020.
24.Leffler DA, Kelly CP, Green PH, et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet：a randomized controlled trial. Gastroenterology. 2015；148：1311-1319.
25.Michielan A, DIncà R. Intestinal permeability in inflammatory bowel disease：pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators of inflammation. 2015；2015：1-10.
26.Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohns disease：role of CARD15 3020insC mutation? Gut. 2006；55(3)：342-347.
27.Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome：methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012；303：G775-G785.
28.Dincà R, De Leo V, Corrao G, et al. Intestinal permeability test as a predictor of clinical course in Crohns disease. Am J Gastroenterol. 1999；94：2956-2960.
29.Quigley EM. Leaky gut-concept or clinical entity? Curr Opin Gastroenterol. 2016；32(2)：74-79.
30.Wu LL, Peng WH, Kuo WT, et al. Commensal bacterial endocytosis inepithelial cells is dependent on myosin light chain kinase-activated brush border fanning by interferon-g. Am J Pathol 2014；184：2260-2274.
31.Karl JP, Margolis LM, Madslien EH, et al. Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress. Am J Physiol Gastrointest Liver Physiol. 2017；312：G559-G571.
32.Marchbank T, Davison G, Oakes JR, et al. The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes. Am J Physiol Gastrointest Liver Physiol. 2011；300：G477-G484.
33.Mahmood A, FitzGerald AJ, Marchbank T, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes.Gut. 2007；56：168-175.
34.Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients：a connection between endogenous alcohol and NASH. Hepatology. 2013；57：601-609.
35.Ponziani FR, Zocco MA, Cerrito L, et al. Bacterial translocation in patients with liver cirrhosis：physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018；12：641-656.
36.Harris JK, Fang R, Wagner BD, et al. Esophageal microbiome in eosinophilic esophagitis. PLoS One 2015；10：e0128346
37.Benitez AJ, Hoffmann C, Muir AB, et al. Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome 2015；3：23
38.Leung AJT, Persad S, Slae M, et al. Intestinal and gastric permeability in children with eosinophilic esophagitis and reflux esophagitis. J Pediatr Gastroenterol Nutr. 2015；60：236-239.
39.Katzka DA, Geno DM, Blair HE, et al. Small intestinal permeability in patients with eosinophilic oesophagitis during active phase and remission. Gut. 2015；64：538-543.
40.Meng X, Li S, Li Y, et al. Gut microbiota`s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics. Nutrients. 2018, 10(10)：C457.
41.Zhou Q, Verne ML, Fields JZ, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019, 68：996-1002.
42.Chelakkot C, Choi Y, Kim D-K, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med 2018；50：e450.
43.Yin M, Yan X, Weng W, et al. Micro-integral membrane protein (MIMP), a newly discovered anti-inflammatory protein of Lactobacillus Plantarum, enhances the gut barrier and modulates microbiota and inflammatory cytokines. Cell Physiol Biochem. 2018；45：474-490.
44.Zhou YP, Jiang ZM, Sun YH, et al. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns：a randomized, doubleblind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003；27：241-245.
45.Hulsewé KW, van Acker BA, Hameeteman W, et al. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability? Clin Nutr. 2004；23：1217-1225.
46.Benjamin J, Makharia G, Ahuja V, et al. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn`s disease：a randomized controlled trial. Dig Dis Sci. 2012；57：1000-1012.
47.Sequeira IR, Kruger MC, Hurst RD, et al. Ascorbic acid may exacerbate aspirininduced increase in intestinal permeability. Basic Clin Pharmacol Toxicol. 2015；117：195-203.
48.Shulman RJ, Hollister EB, Cain K, et al. Psyllium fiber reduces abdominal pain inchildren with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2017；15：712-719.
49.Del Piano M, Balzarini M, Carmagnola S, et al. Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier：a pilot study. J Clin Gastroenterol. 2014；48(Suppl 1)：S56-S61.
50.Krawczyk M, Maciejewska D, Ryterska K, et al. Gut permeability might be improved by dietary fiber in individuals with nonalcoholic fatty liver disease (NAFLD) undergoing weight reduction. Nutrients. 2018；10：1793.